{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T16:42:17Z","timestamp":1789231337838,"version":"build-2803163510"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>The aim of this review article is to present current recommendations regarding the use of hypertonic saline and mannitol for the treatment of intracranial hypertension.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>In recent years, a significant number of studies have been published comparing hypertonic saline with mannitol in patients with acute increased intracranial pressure, mostly caused by traumatic brain injury. Albeit several randomized controlled trials, systematic reviews and meta-analysis support hypertonic saline as more effective than mannitol in reducing intracranial pressure, no clear benefit in regards to the long-term neurologic outcome of these patients has been reported.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Identifying and treating increased intracranial pressure is imperative in neurocritical care settings and proper management is essential to improve long-term outcomes. Currently, there is insufficient evidence from comparative studies to support a formal recommendation on the use of any specific hyperosmolar medication in patients with acute increased intracranial pressure.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aco.0000000000001152","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T08:02:22Z","timestamp":1657008142000},"page":"555-561","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Salted or sweet? Hypertonic saline or mannitol for treatment of intracranial hypertension"],"prefix":"10.1097","volume":"35","author":[{"given":"Massimo","family":"Lamperti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco A.","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Tufegdzic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,7,5]]},"reference":[{"key":"R1-20250601","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ncl.2008.02.003","article-title":"Management of intracranial hypertension","volume":"26","author":"Rangel-Castilla","year":"2008","journal-title":"Neurol Clin"},{"key":"R2-20250601","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1152\/ajplegacy.1919.48.4.531","article-title":"Experimental alteration of brain bulk","volume":"48","author":"Weed","year":"1919","journal-title":"Am J Physiol"},{"key":"R3-20250601","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s12028-020-00959-7","article-title":"Guidelines for the acute treatment of cerebral edema in neurocritical care patients","volume":"32","author":"Cook","year":"2020","journal-title":"Neurocrit Care"},{"key":"R4-20250601","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1001\/archneur.1961.00450080082009","article-title":"Effect of mannitol on cerebrospinal fluid pressure. The actions of hypertonic mannitol solutions and of urea compared","volume":"4","author":"Wise","year":"1961","journal-title":"Arch Neurol"},{"key":"R5-20250601","first-page":"398","article-title":"Use of hypertonic mannitol solutions to lower cerebrospinal fluid pressure and decrease brain bulk in man","volume":"12","author":"Wise","year":"1961","journal-title":"Surg Forum"},{"key":"R6-20250601","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/bjaceaccp\/mkr063","article-title":"Mannitol: a review of its clinical uses","volume":"12","author":"Shawkat","year":"2012","journal-title":"Continuing Educ Anaesth Crit Care Pain"},{"key":"R7-20250601","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/ANA.0000000000000585","article-title":"Mannitol improves intraoperative brain relaxation in patients with a midline shift undergoing supratentorial tumor surgery: a randomized controlled trial","volume":"32","author":"Li","year":"2020","journal-title":"J Neurosurg Anesthesiol"},{"key":"R8-20250601","doi-asserted-by":"crossref","first-page":"39","DOI":"10.14740\/jcs389","article-title":"Comparison of 3% vs. 23.4% hypertonic saline in traumatic brain injury","volume":"9","author":"Traficante","year":"2019","journal-title":"J Curr Surg"},{"key":"R9-20250601","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1097\/CCM.0b013e31827ca4b3","article-title":"High-osmolarity saline in neurocritical care: systematic review and meta-analysis","volume":"41","author":"Lazaridis","year":"2013","journal-title":"Crit Care Med"},{"key":"R10-20250601","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1001\/jama.2021.5561","article-title":"Effect of Continuous Infusion of Hypertonic Saline vs Standard Care on 6-Month Neurological Outcomes in Patients with Traumatic Brain Injury: The COBI Randomized Clinical Trial","volume":"325","author":"Roquilly","year":"2021","journal-title":"JAMA"},{"key":"R11-20250601","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1227\/NEU.0000000000001432","article-title":"Guidelines for the management of severe traumatic brain injury. 4th ed","volume":"80","author":"Carney","year":"2017","journal-title":"Neurosurgery"},{"key":"R12-20250601","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/bja\/aew096","article-title":"Definition, evaluation, and management of brain relaxation during craniotomy","volume":"116","author":"Li","year":"2016","journal-title":"Br J Anaesth"},{"key":"R13-20250601","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/ANA.0000000000000446","article-title":"Comparison of 3% hypertonic saline and 20% mannitol for reducing intracranial pressure in patients undergoing supratentorial brain tumor surgery: a randomized, double-blind clinical trial","volume":"30","author":"Ali","year":"2018","journal-title":"J Neurosurg Anesthesiol"},{"key":"R14-20250601","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4103\/0028-3886.279671","article-title":"A comparison of hypertonic saline and mannitol on intraoperative brain relaxation in patients with raised intracranial pressure during supratentorial tumors resection: a randomized control trial","volume":"68","author":"Singla","year":"2020","journal-title":"Neurol India"},{"key":"R15-20250601","doi-asserted-by":"crossref","first-page":"997","DOI":"10.23736\/S0375-9393.21.15448-3","article-title":"Evaluation of equiosmolar 20% mannitol, 3% hypertonic saline and 8.4% sodium bicarbonate on intraoperative brain relaxation and hemodynamic parameters in patients undergoing craniotomy for supratentorial tumors: a prospective randomized study","volume":"87","author":"Barik","year":"2021","journal-title":"Minerva Anestesiol"},{"key":"R16-20250601","article-title":"Comparison of equiosmolar doses of 7.5% hypertonic saline and 20% mannitol on cerebral oxygenation status and release of brain injury markers during supratentorial craniotomy: a randomized controlled trial","author":"Tsaousi","year":"2021","journal-title":"J Neurosurg Anesthesiol"},{"key":"R17-20250601","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1016\/j.wneu.2019.01.051","article-title":"A comparative study of bolus dose of hypertonic saline, mannitol, and mannitol plus glycerol combination in patients with severe traumatic brain injury","volume":"125","author":"Patil","year":"2019","journal-title":"World Neurosurg"},{"key":"R18-20250601","doi-asserted-by":"crossref","first-page":"e22004","DOI":"10.1097\/MD.0000000000022004","article-title":"Equimolar doses of hypertonic agents (saline or mannitol) in the treatment of intracranial hypertension after severe traumatic brain injury","volume":"99","author":"Huang","year":"2020","journal-title":"Medicine"},{"key":"R19-20250601","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/neuros\/nyz046","article-title":"Hypertonic saline is superior to mannitol for the combined effect on intracranial pressure and cerebral perfusion pressure burdens in patients with severe traumatic brain injury","volume":"86","author":"Mangat","year":"2020","journal-title":"Neurosurgery"},{"key":"R20-20250601","first-page":"CD010904","article-title":"Hypertonic saline versus other intracranial pressure-lowering agents for people with acute traumatic brain injury","volume":"1","author":"Chen","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"R21-20250601","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s40560-020-00476-x","article-title":"Yokobori S; Japan Resuscitation Council (JRC) Neuroresuscitation Task Force and the Guidelines Editorial Committee. Effects of hypertonic saline versus mannitol in patients with traumatic brain injury in prehospital, emergency department, and intensive care unit settings: a systematic review and meta-analysis","volume":"8","author":"Miyoshi","year":"2020","journal-title":"J Intensive Care"},{"key":"R22-20250601","doi-asserted-by":"crossref","first-page":"e21655","DOI":"10.1097\/MD.0000000000021655","article-title":"Hypertonic saline and mannitol in patients with traumatic brain injury: a systematic and meta-analysis","volume":"99","author":"Shi","year":"2020","journal-title":"Medicine"},{"key":"R23-20250601","doi-asserted-by":"crossref","first-page":"765784","DOI":"10.3389\/fsurg.2021.765784","article-title":"Hypertonic saline compared to mannitol for the management of elevated intracranial pressure in traumatic brain injury: a meta-analysis","volume":"8","author":"Han","year":"2022","journal-title":"Front Surg"},{"key":"R24-20250601","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/ANA.0000000000000644","article-title":"Hypertonic saline versus mannitol for traumatic brain injury: a systematic review and meta-analysis with trial sequential analysis","volume":"33","author":"Schwimmbeck","year":"2021","journal-title":"J Neurosurg Anesthesiol"},{"key":"R25-20250601","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/1751143720901690","article-title":"Sugar or salt ('SOS\u2019): a protocol for a UK multicentre randomised trial of mannitol and hypertonic saline in severe traumatic brain injury and intracranial hypertension","volume":"23","author":"Rowland","year":"2022","journal-title":"J Intensive Care Soc"}],"container-title":["Current Opinion in Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACO.0000000000001152","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T22:01:40Z","timestamp":1748815300000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ACO.0000000000001152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/aco.0000000000001152","relation":{},"ISSN":["0952-7907","1473-6500"],"issn-type":[{"value":"0952-7907","type":"print"},{"value":"1473-6500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,5]]}}}